Reversing Aging in Human Cells

They just treated the first human in a groundbreaking clinical trial that could make old cells act young again—by flipping on three genes to partially reprogram aged cells. Targeting glaucoma, this gene therapy aims to regenerate damaged optic nerves, inspired by promising mouse studies. The company, Life Biosciences, has tested it safely in animals and is using a virus with an off-switch to control gene activation via an antibiotic. With only 12 patients planned initially, the eye’s relative safety makes it an ideal starting point—but the big question remains: can this truly reverse aging without triggering cancer or becoming a fad that derails the field? Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2248b975769773f1